![](/img/cover-not-exists.png)
Sustained immune control in HBeAg-positive patients who switched from entecavir therapy to pegylated interferon-α2a: 1-year follow-up of the OSST study
Han, Meifang, Jiang, Jiaji, Hou, Jinlin, Tan, Deming, Sun, Yongtao, Zhao, Mianzhi, Ning, QinVolume:
21
Year:
2016
Language:
english
Journal:
Antiviral Therapy
DOI:
10.3851/imp3019
File:
PDF, 250 KB
english, 2016